Toward clinically relevant clinical trials

L. Eugene Arnold, Kimberly Hoagwood, Peter S. Jensen, Benedetto Vitiello

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This article grapples with two closely related tensions threatening the credibility and relevance of clinical trials to clinicians as well as patients and their families: (1) the tension between clinical flexibility and scientific standardization of protocol and (2) the tension between the need to ensure scientific integrity through a standard, pre-specified protocol and the need to increase compliance by involving patients and their families in goal setting and treatment planning. We propose four partial solutions: (1) relaxed exclusion criteria to maximize generalizability, using only those exclusion criteria essential to the treatment; (2) extensive use of clinical algorithms to incorporate clinical flexibility in a standardized way; (3) active involvement of therapists in decision-making, including cross-site clinical decision panels; and (4) active involvement of families through a goal-setting and treatment-planning session as the first step of treatment. Although we focus on clinical trials with children and adolescents, the principles and ideas may also apply to clinical trials with patients of any age. This article summarizes and elaborates on presentations made by three of the authors at workshops on psychiatric clinical trials in children and adolescents at the May 1996 New Clinical Drug Evaluation Unit (NCDEU) meeting. The focus was on enhancing the clinical relevance of clinical trials-making the results useful and credible to practitioners and patients and their families.

Original languageEnglish (US)
Pages (from-to)135-142
Number of pages8
JournalPsychopharmacology Bulletin
Volume33
Issue number1
StatePublished - 1997
Externally publishedYes

Fingerprint

Clinical Trials
Drug Evaluation
Therapeutics
Patient Compliance
Psychiatry
Decision Making
Education

Keywords

  • algorithm
  • clinician
  • patient
  • research
  • services
  • treatment

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Arnold, L. E., Hoagwood, K., Jensen, P. S., & Vitiello, B. (1997). Toward clinically relevant clinical trials. Psychopharmacology Bulletin, 33(1), 135-142.

Toward clinically relevant clinical trials. / Arnold, L. Eugene; Hoagwood, Kimberly; Jensen, Peter S.; Vitiello, Benedetto.

In: Psychopharmacology Bulletin, Vol. 33, No. 1, 1997, p. 135-142.

Research output: Contribution to journalArticle

Arnold, LE, Hoagwood, K, Jensen, PS & Vitiello, B 1997, 'Toward clinically relevant clinical trials', Psychopharmacology Bulletin, vol. 33, no. 1, pp. 135-142.
Arnold LE, Hoagwood K, Jensen PS, Vitiello B. Toward clinically relevant clinical trials. Psychopharmacology Bulletin. 1997;33(1):135-142.
Arnold, L. Eugene ; Hoagwood, Kimberly ; Jensen, Peter S. ; Vitiello, Benedetto. / Toward clinically relevant clinical trials. In: Psychopharmacology Bulletin. 1997 ; Vol. 33, No. 1. pp. 135-142.
@article{2f084f3a7b3c42d7af1b31d6138eac2c,
title = "Toward clinically relevant clinical trials",
abstract = "This article grapples with two closely related tensions threatening the credibility and relevance of clinical trials to clinicians as well as patients and their families: (1) the tension between clinical flexibility and scientific standardization of protocol and (2) the tension between the need to ensure scientific integrity through a standard, pre-specified protocol and the need to increase compliance by involving patients and their families in goal setting and treatment planning. We propose four partial solutions: (1) relaxed exclusion criteria to maximize generalizability, using only those exclusion criteria essential to the treatment; (2) extensive use of clinical algorithms to incorporate clinical flexibility in a standardized way; (3) active involvement of therapists in decision-making, including cross-site clinical decision panels; and (4) active involvement of families through a goal-setting and treatment-planning session as the first step of treatment. Although we focus on clinical trials with children and adolescents, the principles and ideas may also apply to clinical trials with patients of any age. This article summarizes and elaborates on presentations made by three of the authors at workshops on psychiatric clinical trials in children and adolescents at the May 1996 New Clinical Drug Evaluation Unit (NCDEU) meeting. The focus was on enhancing the clinical relevance of clinical trials-making the results useful and credible to practitioners and patients and their families.",
keywords = "algorithm, clinician, patient, research, services, treatment",
author = "Arnold, {L. Eugene} and Kimberly Hoagwood and Jensen, {Peter S.} and Benedetto Vitiello",
year = "1997",
language = "English (US)",
volume = "33",
pages = "135--142",
journal = "Psychopharmacology Bulletin",
issn = "0048-5764",
publisher = "MedWorks Media LLC",
number = "1",

}

TY - JOUR

T1 - Toward clinically relevant clinical trials

AU - Arnold, L. Eugene

AU - Hoagwood, Kimberly

AU - Jensen, Peter S.

AU - Vitiello, Benedetto

PY - 1997

Y1 - 1997

N2 - This article grapples with two closely related tensions threatening the credibility and relevance of clinical trials to clinicians as well as patients and their families: (1) the tension between clinical flexibility and scientific standardization of protocol and (2) the tension between the need to ensure scientific integrity through a standard, pre-specified protocol and the need to increase compliance by involving patients and their families in goal setting and treatment planning. We propose four partial solutions: (1) relaxed exclusion criteria to maximize generalizability, using only those exclusion criteria essential to the treatment; (2) extensive use of clinical algorithms to incorporate clinical flexibility in a standardized way; (3) active involvement of therapists in decision-making, including cross-site clinical decision panels; and (4) active involvement of families through a goal-setting and treatment-planning session as the first step of treatment. Although we focus on clinical trials with children and adolescents, the principles and ideas may also apply to clinical trials with patients of any age. This article summarizes and elaborates on presentations made by three of the authors at workshops on psychiatric clinical trials in children and adolescents at the May 1996 New Clinical Drug Evaluation Unit (NCDEU) meeting. The focus was on enhancing the clinical relevance of clinical trials-making the results useful and credible to practitioners and patients and their families.

AB - This article grapples with two closely related tensions threatening the credibility and relevance of clinical trials to clinicians as well as patients and their families: (1) the tension between clinical flexibility and scientific standardization of protocol and (2) the tension between the need to ensure scientific integrity through a standard, pre-specified protocol and the need to increase compliance by involving patients and their families in goal setting and treatment planning. We propose four partial solutions: (1) relaxed exclusion criteria to maximize generalizability, using only those exclusion criteria essential to the treatment; (2) extensive use of clinical algorithms to incorporate clinical flexibility in a standardized way; (3) active involvement of therapists in decision-making, including cross-site clinical decision panels; and (4) active involvement of families through a goal-setting and treatment-planning session as the first step of treatment. Although we focus on clinical trials with children and adolescents, the principles and ideas may also apply to clinical trials with patients of any age. This article summarizes and elaborates on presentations made by three of the authors at workshops on psychiatric clinical trials in children and adolescents at the May 1996 New Clinical Drug Evaluation Unit (NCDEU) meeting. The focus was on enhancing the clinical relevance of clinical trials-making the results useful and credible to practitioners and patients and their families.

KW - algorithm

KW - clinician

KW - patient

KW - research

KW - services

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=0030895124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030895124&partnerID=8YFLogxK

M3 - Article

C2 - 9133765

AN - SCOPUS:0030895124

VL - 33

SP - 135

EP - 142

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

SN - 0048-5764

IS - 1

ER -